Live from the NIH registry
Studies recruiting near Frederick right now
Top 25 of 261 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Cumberland Valley Retina Consultants PC — Hagerstown, Maryland (21.7 mi)
· Sponsor: Genentech, Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research - Maryland (Matthew L. Mintz, MD, FACP) — Rockville, Maryland (27.9 mi)
· Sponsor: Crystalys Therapeutics
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Cumberland Valley Retina Consultants,P.C. — Hagerstown, Maryland (21.7 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Cataract
Phase 3
Interventional 528 participants sought
Maryland Vision Institute — Hagerstown, Maryland (21.7 mi)
· Sponsor: Melt Pharmaceuticals
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation
HIV Infections, Substance Use Disorders
N/A
Interventional 360 participants sought
Frederick County Health Department, Street Safe Program — Frederick, Maryland (1.4 mi)
· Sponsor: Johns Hopkins University
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Pleuropulmonary Blastoma, Cystic Nephroma
N/A
Observational 1,500 participants sought
National Cancer Institute - Shady Grove — Rockville, Maryland (27.9 mi)
· Sponsor: National Cancer Institute (NCI)
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Schizophrenia
Phase 3
Interventional 690 participants sought
Reviva site — Gaithersburg, Maryland (23.1 mi)
· Sponsor: Reviva Pharmaceuticals
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 180 participants sought
Lawrence J Green, MD LLC — Rockville, Maryland (27.9 mi)
· Sponsor: Organon and Co
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Dermatology Associates Pc — Rockville, Maryland (27.9 mi)
· Sponsor: Incyte Corporation
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma
Phase 3
Interventional 1,450 participants sought
Frederick Memorial Hospital — Frederick, Maryland (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Post Traumatic Stress Disorder, PTSD
Phase 2
Interventional 70 participants sought
Sunstone Medical, PC — Rockville, Maryland (27.9 mi)
· Sponsor: Sunstone Medical
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Healthy
Phase 3
Interventional 60,000 participants sought
C.W. Bill Young Marrow Donor Center — Rockville, Maryland (27.9 mi)
· Sponsor: Center for International Blood and Marrow Transplant Research
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (29.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
CBH Health — Gaithersburg, Maryland (23.1 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 4,300 participants sought
Research Site — Frederick, Maryland (1.4 mi)
· Sponsor: AstraZeneca
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (29.4 mi)
· Sponsor: NRG Oncology
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Phase 3
Interventional 284 participants sought
Adverum Clinical Site 197 — Hagerstown, Maryland (21.7 mi)
· Sponsor: Adverum Biotechnologies, Inc.
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Phase 2
Interventional 100 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (21.7 mi)
· Sponsor: Vantage Biosciences Ltd
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Schizophrenia
Phase 3
Interventional 284 participants sought
Neurocrine Clinical Site — Gaithersburg, Maryland (23.1 mi)
· Sponsor: Neurocrine Biosciences
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
William E Kahlert Regional Cancer Center/Sinai Hospital — Westminster, Maryland (24.4 mi)
· Sponsor: Wake Forest University Health Sciences
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Non-small Cell Lung Cancer
Phase 2, Phase 3
Interventional 1,260 participants sought
Frederick Health Hospital- James M Stockman Cancer Institute — Frederick, Maryland (1.4 mi)
· Sponsor: BioNTech SE
Evaluating the Status of Complex Aneuploidy to Locate Additional Transferrable Embryos
Complex Aneuploidy, Chaotic Aneuploidy
N/A
Observational 280 participants sought
Shady Grove Fertility — Rockville, Maryland (27.9 mi)
· Sponsor: Shady Grove Fertility Reproductive Science Center
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Rockville — Rockville, Maryland (27.9 mi)
· Sponsor: Sparrow Pharmaceuticals
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Geographic Atrophy of the Macula
Phase 2
Interventional 110 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (21.7 mi)
· Sponsor: Galimedix Therapeutics Inc
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 850 participants sought
Neurocrine Clinical Site — Gaithersburg, Maryland (23.1 mi)
· Sponsor: Neurocrine Biosciences